COVID-19 trials registries data warehouse

http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49295

DR VIJAY KUMAR

vijaykr@aiimspatna.org

2020-11-19

Not recruiting

RCT

Randomized

Parallel

Blind label

multi-center

Treatment

All patients above the age of 18 years both males and females, admitted with a diagnosis of <br/ >Moderate &amp, Severe COVID -19 (on the basis of a positive RT-PCR report) at our facility during the <br/ >study period (16/08/2020-15/12/2020)

1. Patients with a known allergy to or adverse drug reaction with vitamin C. <br/ >2. Patients unable to provide consent or unwilling to participate in the study. <br/ >3. Patients participating in any other ongoing clinical trial will be excluded from the study. <br/ >4. Patients below the age of 18 years will be excluded from the study. <br/ >5. Pregnant or Breastfeeding Females will be excluded from the study. <br/ >6.Patients previously complicated with End-stage Lung Disease, End stage Malignancy, Glucose-6- <br/ >Phosphate dehydrogenase deficiency, Diabetes Mellitus &amp, Diabetic Ketoacidosis , Nephrolithiasis, <br/ >Chronic Kidney Disease, Cardiogenic Pulmonary Edema will be Excluded from the study.

2

Not reported

18

75

India

Moderate/severe disease at enrollment

4: Moderate/severe disease at enrollment

80

1. Clinical Recovery From the disease . <br/ >2. In Hospital Mortality .Timepoint: AT WEEKLY INTERVAL

| Declared number of arm (2.0) differs from found arms (3.0)

Phase 3

[{"arm_notes": "", "treatment_id": 1369, "treatment_name": "Vitamin c", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]